PD-L1 Expression in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 Expression in Triple-Negative Breast Cancer

Published:2014-01-10 Issue:4 Volume:2 Page:361-370
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Mittendorf Elizabeth A.,Philips Anne V.,Meric-Bernstam Funda,Qiao Na,Wu Yun,Harrington Susan,Su Xiaoping,Wang Ying,Gonzalez-Angulo Ana M.,Akcakanat Argun,Chawla Akhil,Curran Michael,Hwu Patrick,Sharma Padmanee,Litton Jennifer K.,Molldrem Jeffrey J.,Alatrash Gheath

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 1045 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving immunotherapeutic solutions for triple-negative breast carcinoma;Cancer Treatment Reviews;2024-11

2. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10

3. The relationship between tumor immunity and the cGAS–STING pathway in breast cancer: An immunohistochemical study;Experimental and Molecular Pathology;2024-10

4. PD-L1 expression and tumor-infiltrating lymphocytes: Correlations and prognostic values in Chinese triple-negative breast cancer patients with different molecular subtyping;Pathology - Research and Practice;2024-10

5. FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells;Biomedicine & Pharmacotherapy;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP